Parkwood LLC’s Evolent Health EVH Stock Holding History

Parkwood LLC’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-12,362	Closed	-$236K	–	101
2024 Q2	$236K	Buy	+12,362	New	+$316K	0.03%	114

Other funds holding EVH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Parkwood LLC's EVH Position: Q3 2024 in Review

Parkwood LLC sold out of Evolent Health (EVH) in Q3 2024, closing a stake of 12,362 shares — an estimated $236K sold.

Parkwood LLC first reported a position in EVH in Q2 2024 and held it in 1 quarter. The position peaked at $236K in Q2 2024. 262 funds tracked by Wall St. Rank hold EVH as of Q3 2024.

Parkwood LLC reported no remaining Evolent Health position as of Q3 2024 after selling out during the quarter.
Parkwood LLC sold 12,362 Evolent Health shares in Q3 2024, an estimated $236K.
Parkwood LLC first reported a position in Evolent Health in Q2 2024 and held it in 1 quarter.
Parkwood LLC's Evolent Health position peaked at $236K in Q2 2024.
262 funds tracked by Wall St. Rank held Evolent Health as of Q3 2024.

Based on Parkwood LLC's 13F filing for Q3 2024, filed 14 Nov 2024.